Search Results for: Bausch
![](https://www.optiknow.ca/wp-content/uploads/2020/08/Bausch-Health-logo-810X338px.jpg)
Bausch + Lomb and Clearside Biomedical Announce U.S. FDA Filing Acceptance for XIPERE
Friday, June 4 2021 | 15 h 48 min | News, Press Release
Bausch + Lomb, along with Clearside Biomedical, a biopharmaceutical company dedicated to developing and delivering treatments that restore and...
Read More![](https://www.optiknow.ca/wp-content/uploads/2019/01/Bausch-Lomb-810X338px.jpg)
Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry Eye, News, Press Release
Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...
Read More![](https://www.optiknow.ca/wp-content/uploads/2020/08/Bausch-Health-logo-810X338px.jpg)
Bausch Advances Novel Dry Eye Therapeutic to Phase 3
Tuesday, December 29 2020 | 07 h 28 min | Dry Eye, Latest News, News, Vision Science
Quebec based B+L has announced the second of two Phase 3 studies studies evaluating the investigational treatment NOV03 (perfluorohexyloctane) as a...
Read More![](https://www.optiknow.ca/wp-content/uploads/2019/01/Bausch-Lomb-810X338px.jpg)
Bausch + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled
Monday, November 16 2020 | 10 h 26 min | News, Press Release
Bausch + Lomb announced that its exclusive ONE by ONE Recycling program has recycled nearly 27 million used contact lenses, top foils and...
Read More![](https://www.optiknow.ca/wp-content/uploads/2020/08/Bausch-Health-logo-810X338px.jpg)
Bausch Health to Acquire Option to Purchase Allegro Ophthalmics Assets
Tuesday, September 22 2020 | 10 h 04 min | News, Press Release
Bausch Health Companies Inc and Bausch + Lomb and Allegro Ophthalmics a privately held biopharmaceutical company focused on the development of novel...
Read More